SPL 0.00% 9.7¢ starpharma holdings limited

Ann: VivaGel BV phase 3 trials for prevention of BV completed, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 357 Posts.
    lightbulb Created with Sketch. 31
    The previous trial wouldn't have been regarded as a success by the FDA, I beleive thats why they are preparing a submisssion for review and hopefully approval.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.